These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 24962384)

  • 21. Leveraging structural information for the discovery of new drugs: computational methods.
    Nguyen TB; Wong SE; Lightstone FC
    Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The global need for effective antibiotics: challenges and recent advances.
    Högberg LD; Heddini A; Cars O
    Trends Pharmacol Sci; 2010 Nov; 31(11):509-15. PubMed ID: 20843562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Lactam and glycopeptide antibiotics: first and last line of defense?
    Jovetic S; Zhu Y; Marcone GL; Marinelli F; Tramper J
    Trends Biotechnol; 2010 Dec; 28(12):596-604. PubMed ID: 20970210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
    Martelli G; Giacomini D
    Eur J Med Chem; 2018 Oct; 158():91-105. PubMed ID: 30205261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The search for novel antibiotics--strategies and current approaches].
    Schmid P
    Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):498-512. PubMed ID: 25872259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alternative natural sources for a new generation of antibacterial agents.
    Taylor PW
    Int J Antimicrob Agents; 2013 Sep; 42(3):195-201. PubMed ID: 23796893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
    Wiles JA; Bradbury BJ; Pucci MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nature's clarion call of antibacterial resistance: are we listening?
    Theuretzbacher U; Toney JH
    Curr Opin Investig Drugs; 2006 Feb; 7(2):158-66. PubMed ID: 16499286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs for bad bugs: confronting the challenges of antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Pompliano DL
    Nat Rev Drug Discov; 2007 Jan; 6(1):29-40. PubMed ID: 17159923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening strategies for discovery of antibacterial natural products.
    Singh SB; Young K; Miesel L
    Expert Rev Anti Infect Ther; 2011 Aug; 9(8):589-613. PubMed ID: 21819327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of antibacterial discovery revisited.
    Gwynn MN; Portnoy A; Rittenhouse SF; Payne DJ
    Ann N Y Acad Sci; 2010 Dec; 1213():5-19. PubMed ID: 21058956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting current understanding of antibiotic action for discovery of new drugs.
    Chopra I; Hesse L; O'Neill AJ
    Symp Ser Soc Appl Microbiol; 2002; (31):4S-15S. PubMed ID: 12481824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational design, synthesis, and biological evaluation of lactam-bridged gramicidin A analogues: discovery of a low-hemolytic antibacterial peptide.
    Mao J; Kuranaga T; Hamamoto H; Sekimizu K; Inoue M
    ChemMedChem; 2015 Mar; 10(3):540-5. PubMed ID: 25510221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis.
    Borrero NV; Bai F; Perez C; Duong BQ; Rocca JR; Jin S; Huigens RW
    Org Biomol Chem; 2014 Feb; 12(6):881-6. PubMed ID: 24389824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.
    Tse-Dinh YC
    Future Med Chem; 2015; 7(4):459-71. PubMed ID: 25875873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
    Gadakh B; Van Aerschot A
    Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and Discovery of New Antibacterial Agents: Advances, Perspectives, Challenges.
    Jampilek J
    Curr Med Chem; 2018; 25(38):4972-5006. PubMed ID: 28925868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.